ScreenerHero

SHC Sotera Health Company

NAS · US · Healthcare · Diagnostics & Research · soterahealth.com
18.55USD+1.81%Mkt Cap: 5.29B $P/E: 32.54

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segment…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap5.29B USD
Enterprise Value7.11B USD
Revenue (TTM)1.22B USD
Gross Profit645.53M USD
Net Income (TTM)77.95M USD
Revenue/Share4.27 USD
Last Price18.55 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)32.54
P/E (Forward)16.95
PEG1.31
EV/EBITDA12.33
EV/Revenue5.85
P/S4.28
P/B7.81
EPS (TTM)0.57
EPS (Forward)1.07
52W Range
13.0981% of range19.85
52W High19.85 USD
52W Low13.09 USD
Profitability
Gross Margin55.48%
Oper. Margin37.96%
EBITDA Margin47.41%
Profit Margin6.70%
ROE12.86%
ROA2.39%
Growth
Revenue Growth9.20%
Earnings Growth569.50%
Cash Flow & Leverage
Operating CF287.19M USD
CapEx (TTM)138.02M USD
FCF Margin12.66%
FCF Yield2.91%
Net Debt1.91B USD
Net Debt/EBITDA3.31
Balance Sheet
Debt/Equity3.75
Current Ratio2.80
Quick Ratio2.40
Book Value/Sh2.33 USD
Cash/Share1.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.72 USD
Upside (mean)+22.5%
Target Range18.00 USD – 25.00 USD
18.00+22.5% to mean25.00
# Analysts9
Ownership
Shares Out.285.37M
Float185.23M
Insiders2.40%
Institutions105.92%
Short Interest
Short Ratio5.5d
Short % Float4.96%
Short % Out.4.30%
Shares Short12.27M
Short (prev mo.)12.12M
Technical
SMA 5018.63 (-0.4%)
SMA 20016.99 (+9.2%)
Beta1.78
S&P 52W Chg14.58%
Avg Vol (30d)2.16M
Avg Vol (10d)1.66M
Technical Indicators
RSI (14)50.9
MACD-0.0426
MACD Signal0.0033
MACD Hist.-0.0459
BB Upper19.08 USD
BB Middle18.54 USD
BB Lower18.01 USD
BB Width5.76%
ATR (14)0.4632 USD
Vol Ratio (20d)1.30x